Accueil > Actualité
Actualite financiere : Actualite bourse

AstraZeneca: FDA extends approval of Enhertu

( - AstraZeneca announced Friday that the US Food and Drug Administration (FDA) has approved Enhertu, the antibody conjugate it is developing with Japan's Daiichi Sankyo, for the treatment of bronchial cancer.

The biopharmaceutical company said that the FDA's approval is for the treatment of adult patients with inoperable or metastatic non-small cell lung cancer with a HER2 gene mutation.

Specifically, the approval is for patients who have received at least one prior therapy and whose disease specificity has been demonstrated by an FDA approved device.

Copyright (c) 2022 All rights reserved.




Qui sommes-nous ? | Nous contacter | FAQ | Mentions légales | RSS | © Copyright 2007 Cercle Finance. Tous droits réservés.
Indices et cours différés d’au moins 15 mn | Cotations boursières fournies par ABC Bourse.